Robotic Assisted Surgery Market
PUBLISHED: 2026 ID: SMRC37408
SHARE
SHARE

Robotic Assisted Surgery Market

Robotic-Assisted Surgery Market Forecasts to 2034 - Global Analysis By Product Type (Surgical Systems, Instruments & Accessories and Services & Maintenance), Surgical Specialty, Technology, End User and By Geography

4.8 (22 reviews)
4.8 (22 reviews)
Published: 2026 ID: SMRC37408

Due to ongoing shifts in global trade and tariffs, the market outlook will be refreshed before delivery, including updated forecasts and quantified impact analysis. Recommendations and Conclusions will also be revised to offer strategic guidance for navigating the evolving international landscape.
Loading...

According to Stratistics MRC, the Global Medical Automation Market is accounted for $62.2 billion in 2026 and is expected to reach $126.8 billion by 2034 growing at a CAGR of 9.3% during the forecast period. Medical automation involves applying modern technologies including robotics, artificial intelligence, and digital data systems to optimize healthcare operations and enhance patient outcomes. It improves diagnostic precision, minimizes mistakes, and boosts efficiency across medical facilities. Automated solutions are widely used in surgical procedures, diagnostic laboratories, medication dispensing, and continuous patient monitoring. The integration of digital healthcare tools enables providers to offer quicker and more dependable services. It also enables predictive analytics that help in early disease identification and customized therapies. In essence, it reshapes healthcare delivery into a highly efficient, accurate, and patient-focused model improving global health standards overall effectively.

According to the International Federation of Robotics (IFR), 517,000 new industrial robots were installed worldwide in 2022, a record high, with healthcare and medical device manufacturing among the fastest-growing application areas.

Market Dynamics:

Driver:

Rising demand for healthcare efficiency


Increasing need for improved efficiency in healthcare operations is strongly driving the medical automation market. Healthcare institutions are implementing automated technologies to simplify administrative processes, manage patients effectively, and optimize clinical workflows. These systems help minimize delays, improve appointment scheduling, and strengthen coordination among medical departments. The growing burden on healthcare facilities due to rising patient numbers is accelerating the adoption of automation solutions. As a result, hospitals are investing in advanced digital technologies that enhance productivity and overall service efficiency across the sector.

Restraint:

High implementation and maintenance costs


The high cost of installation and upkeep acts as a key barrier in the medical automation industry. Implementing sophisticated systems like robotic-assisted surgery platforms, artificial intelligence diagnostic tools, and digital hospital management solutions demands substantial initial capital. In addition, healthcare providers face continuous expenses for software updates, equipment servicing, employee training, and technical assistance. Smaller medical institutions especially find it difficult to invest in such expensive technologies, which restrict adoption. Infrastructure upgrades and security enhancements further add to the financial load. Consequently, limited budgets in many healthcare organizations hinder the rapid expansion and deployment of automation solutions worldwide.

Opportunity:

Expansion of telemedicine and remote healthcare


The growth of telemedicine and remote care services creates significant opportunities for medical automation. Increasing internet access and digital adoption allow healthcare providers to deliver virtual consultations, remote diagnosis, and ongoing patient monitoring. Automated technologies such as artificial intelligence chatbots, wearable monitoring devices, and cloud-based healthcare systems enhance the efficiency of these services. This reduces dependence on physical hospital visits and improves healthcare access in remote and underserved areas. As remote healthcare demand continues to rise, automation plays a crucial role in enabling scalable, efficient, and accessible medical delivery systems.

Threat:

Rapid cybersecurity threats and data breaches


Increasing cybersecurity risks and data breach incidents represent a major threat to the medical automation sector. As healthcare facilities adopt more digital and interconnected systems, they handle large volumes of sensitive patient information, which makes them prime targets for cybercriminal activities. Automated technologies such as artificial intelligence platforms and cloud-based medical records are exposed to hacking attempts, ransomware attacks, and unauthorized data access. The rising complexity of cyber threats undermines confidence in automation solutions and limits their widespread adoption in healthcare environments.

Covid-19 Impact:

The COVID-19 outbreak greatly boosted the medical automation market by speeding up the use of advanced digital healthcare solutions. Healthcare facilities were overwhelmed with rising patient numbers, creating strong demand for automated systems in testing, monitoring, and hospital administration. Artificial intelligence and robotic technologies were widely implemented to limit direct human interaction and reduce infection spread. Remote healthcare services and virtual patient monitoring also expanded rapidly during the crisis. The pandemic emphasized the need for efficient, contact-free medical services. Consequently, healthcare organizations increased spending on automation technologies, leading to lasting changes and growth in the global healthcare sector.

The monitoring & tracking automation systems segment is expected to be the largest during the forecast period

The monitoring & tracking automation systems segment is expected to account for the largest market share during the forecast period because they play a vital role in continuous patient care. These solutions allow real-time observation of essential health indicators like pulse rate, blood pressure, oxygen saturation, and blood glucose levels. They are extensively utilized in hospitals, critical care units, and home-based healthcare environments to enable prompt medical response when needed. Rising cases of chronic illnesses and an expanding elderly population have significantly boosted the need for ongoing health monitoring. Their capability to enhance patient safety, reduce clinical workload, and support remote care services makes them the leading segment in this market.

The home healthcare segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the home healthcare segment is predicted to witness the highest growth rate because of rising demand for individualized and affordable medical services outside hospitals. An increasing aging population and higher incidence of chronic conditions are encouraging the shift toward continuous care in home environments. Automated healthcare tools such as wearable monitoring devices, remote tracking systems, and artificial intelligence-driven health platforms are enhancing the effectiveness of home-based treatment. Both patients and healthcare providers are adopting these solutions to minimize hospital dependency and reduce overall medical expenses. The comfort, convenience, and improved access to healthcare are driving strong expansion in this segment.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share because of its highly developed healthcare systems and early integration of advanced technologies. The region is characterized by significant spending on healthcare, strong digital transformation initiatives, and extensive use of robotics, artificial intelligence, and automated medical solutions. A well-established network of hospitals and the presence of key industry players further strengthen its leading position. In addition, increasing cases of chronic illnesses and a growing elderly population accelerate the adoption of automation technologies, making the region the global leader in this sector.

Region with highest CAGR:

Over the forecast period, the Asia-Pacific region is anticipated to exhibit the highest CAGR because of significant advancements in healthcare infrastructure and rising adoption of digital healthcare technologies. Increasing investments in healthcare systems across countries like China, India, and Japan are supporting the expansion of automation solutions. A large population base, growing burden of chronic diseases, and improved access to medical services are further driving demand. Government initiatives focused on healthcare modernization and digital transformation are strengthening market development. In addition, greater awareness of advanced medical technologies and a large patient population are contributing to rapid market expansion in this region.

Key players in the market

Some of the key players in Medical Automation Market include Siemens Healthineers, Medtronic, Koninklijke Philips N.V., Stryker Corporation, Intuitive Surgical, Abbott Laboratories, Becton, Dickinson and Company (BD), Danaher Corporation, Roche Diagnostics, Johnson & Johnson, Boston Scientific, GE Healthcare, Zimmer Biomet, Olympus Corporation, Accuray Incorporated, Tecan Group, Omnicell, Inc. and Hologic, Inc.

Key Developments:

In February 2026, Siemens Healthineers and Mayo Clinic are expanding their strategic collaboration to enhance patient care for neurodegenerative disease and the management of prostate cancer and metastatic liver tumors. The two organizations have signed an agreement that will improve care for those disease states and expand access to new imaging and interventional technologies.

In February 2026, Medtronic has agreed to acquire CathWorks, an Israeli medtech company focused on the diagnosis and treatment of coronary artery disease, for up to $585 million.  CathWorks is known for its FFRangio technology, which uses advanced artificial intelligence (AI) algorithms and computational science to obtain fractional flow reserve (FFR) measurements of the coronary tree from routine X-ray images.

In November 2025, Abbott and Exact Sciences announced a definitive agreement for Abbott to acquire Exact Sciences, which will enable it to enter and lead in fast-growing cancer diagnostics segments, serving millions more people. Under the terms of the agreement, Exact Sciences shareholders will receive $105 per common share, representing a total equity value of approximately $21 billion.

Product Types Covered:
• Diagnostic Automation Systems
• Therapeutic Automation Systems
• Monitoring & Tracking Automation Systems
• Laboratory Automation Equipment
• Surgical & Procedural Automation Systems

Technologies Covered:
• Robotics & Robotic Process Automation (RPA)
• Artificial Intelligence & Machine Learning
• Internet of Medical Things (IoMT)
• Workflow & Process Management Software
• Imaging & Sensing Automation

Applications Covered:
• Hospitals & Clinics
• Diagnostic Laboratories
• Pharmacies & Drug Dispensing
• Home Healthcare
• Research & Academic Institutes

End Users Covered:
• Healthcare Providers
• Patients
• Research Organizations
• Pharmaceutical & Biotech Companies

Regions Covered:
• North America
o United States
o Canada
o Mexico
• Europe
o United Kingdom
o Germany
o France
o Italy
o Spain
o Netherlands
o Belgium
o Sweden
o Switzerland
o Poland
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o South Korea
o Australia
o Indonesia
o Thailand
o Malaysia
o Singapore
o Vietnam
o Rest of Asia Pacific   
• South America
o Brazil
o Argentina
o Colombia
o Chile
o Peru
o Rest of South America
• Rest of the World (RoW)
o Middle East
§ Saudi Arabia
§ United Arab Emirates
§ Qatar
§ Israel
§ Rest of Middle East
o Africa
§ South Africa
§ Egypt
§ Morocco
§ Rest of Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

 

Table of Contents

1 Executive Summary       
 1.1 Market Snapshot and Key Highlights      
 1.2 Growth Drivers, Challenges, and Opportunities      
 1.3 Competitive Landscape Overview      
 1.4 Strategic Insights and Recommendations      
        
2 Research Framework       
 2.1 Study Objectives and Scope      
 2.2 Stakeholder Analysis      
 2.3 Research Assumptions and Limitations      
 2.4 Research Methodology      
  2.4.1 Data Collection (Primary and Secondary)     
  2.4.2 Data Modeling and Estimation Techniques     
  2.4.3 Data Validation and Triangulation     
  2.4.4 Analytical and Forecasting Approach     
        
3 Market Dynamics and Trend Analysis       
 3.1 Market Definition and Structure      
 3.2 Key Market Drivers      
 3.3 Market Restraints and Challenges      
 3.4 Growth Opportunities and Investment Hotspots      
 3.5 Industry Threats and Risk Assessment      
 3.6 Technology and Innovation Landscape      
 3.7 Emerging and High-Growth Markets      
 3.8 Regulatory and Policy Environment      
 3.9 Impact of COVID-19 and Recovery Outlook      
        
4 Competitive and Strategic Assessment       
 4.1 Porter's Five Forces Analysis      
  4.1.1 Supplier Bargaining Power     
  4.1.2 Buyer Bargaining Power     
  4.1.3 Threat of Substitutes     
  4.1.4 Threat of New Entrants     
  4.1.5 Competitive Rivalry     
 4.2 Market Share Analysis of Key Players      
 4.3 Product Benchmarking and Performance Comparison      
        
5 Global Medical Automation Market, By Product Type       
 5.1 Diagnostic Automation Systems      
 5.2 Therapeutic Automation Systems      
 5.3 Monitoring & Tracking Automation Systems      
 5.4 Laboratory Automation Equipment      
 5.5 Surgical & Procedural Automation Systems      
        
6 Global Medical Automation Market, By Technology       
 6.1 Robotics & Robotic Process Automation (RPA)      
 6.2 Artificial Intelligence & Machine Learning      
 6.3 Internet of Medical Things (IoMT)      
 6.4 Workflow & Process Management Software      
 6.5 Imaging & Sensing Automation      
        
7 Global Medical Automation Market, By Application       
 7.1 Hospitals & Clinics      
 7.2 Diagnostic Laboratories      
 7.3 Pharmacies & Drug Dispensing      
 7.4 Home Healthcare      
 7.5 Research & Academic Institutes      
        
8 Global Medical Automation Market, By End User       
 8.1 Healthcare Providers      
 8.2 Patients      
 8.3 Research Organizations      
 8.4 Pharmaceutical & Biotech Companies      
        
9 Global Medical Automation Market, By Geography       
 9.1 North America      
  9.1.1 United States     
  9.1.2 Canada     
  9.1.3 Mexico     
 9.2 Europe      
  9.2.1 United Kingdom     
  9.2.2 Germany     
  9.2.3 France     
  9.2.4 Italy     
  9.2.5 Spain     
  9.2.6 Netherlands     
  9.2.7 Belgium     
  9.2.8 Sweden     
  9.2.9 Switzerland     
  9.2.10 Poland     
  9.2.11 Rest of Europe     
 9.3 Asia Pacific      
  9.3.1 China     
  9.3.2 Japan     
  9.3.3 India     
  9.3.4 South Korea     
  9.3.5 Australia     
  9.3.6 Indonesia     
  9.3.7 Thailand     
  9.3.8 Malaysia     
  9.3.9 Singapore     
  9.3.10 Vietnam     
  9.3.11 Rest of Asia Pacific     
 9.4 South America      
  9.4.1 Brazil     
  9.4.2 Argentina     
  9.4.3 Colombia     
  9.4.4 Chile     
  9.4.5 Peru     
  9.4.6 Rest of South America     
 9.5 Rest of the World (RoW)      
  9.5.1 Middle East     
   9.5.1.1 Saudi Arabia    
   9.5.1.2 United Arab Emirates    
   9.5.1.3 Qatar    
   9.5.1.4 Israel    
   9.5.1.5 Rest of Middle East    
  9.5.2 Africa     
   9.5.2.1 South Africa    
   9.5.2.2 Egypt    
   9.5.2.3 Morocco    
   9.5.2.4 Rest of Africa    
        
10 Strategic Market Intelligence       
 10.1 Industry Value Network and Supply Chain Assessment      
 10.2 White-Space and Opportunity Mapping      
 10.3 Product Evolution and Market Life Cycle Analysis      
 10.4 Channel, Distributor, and Go-to-Market Assessment      
        
11 Industry Developments and Strategic Initiatives       
 11.1 Mergers and Acquisitions      
 11.2 Partnerships, Alliances, and Joint Ventures      
 11.3 New Product Launches and Certifications      
 11.4 Capacity Expansion and Investments      
 11.5 Other Strategic Initiatives      
        
12 Company Profiles       
 12.1 Siemens Healthineers      
 12.2 Medtronic      
 12.3 Koninklijke Philips N.V.      
 12.4 Stryker Corporation      
 12.5 Intuitive Surgical      
 12.6 Abbott Laboratories      
 12.7 Becton, Dickinson and Company (BD)      
 12.8 Danaher Corporation      
 12.9 Roche Diagnostics      
 12.10 Johnson & Johnson      
 12.11 Boston Scientific      
 12.12 GE Healthcare      
 12.13 Zimmer Biomet      
 12.14 Olympus Corporation      
 12.15 Accuray Incorporated      
 12.16 Tecan Group      
 12.17 Omnicell, Inc.      
 12.18 Hologic, Inc.      
        
List of Tables        
1 Global Medical Automation Market Outlook, By Region (2023-2034) ($MN)       
2 Global Medical Automation Market Outlook, By Product Type (2023-2034) ($MN)       
3 Global Medical Automation Market Outlook, By Diagnostic Automation Systems (2023-2034) ($MN)       
4 Global Medical Automation Market Outlook, By Therapeutic Automation Systems (2023-2034) ($MN)       
5 Global Medical Automation Market Outlook, By Monitoring & Tracking Automation Systems (2023-2034) ($MN)       
6 Global Medical Automation Market Outlook, By Laboratory Automation Equipment (2023-2034) ($MN)       
7 Global Medical Automation Market Outlook, By Surgical & Procedural Automation Systems (2023-2034) ($MN)       
8 Global Medical Automation Market Outlook, By Technology (2023-2034) ($MN)       
9 Global Medical Automation Market Outlook, By Robotics & Robotic Process Automation (RPA) (2023-2034) ($MN)       
10 Global Medical Automation Market Outlook, By Artificial Intelligence & Machine Learning (2023-2034) ($MN)       
11 Global Medical Automation Market Outlook, By Internet of Medical Things (IoMT) (2023-2034) ($MN)       
12 Global Medical Automation Market Outlook, By Workflow & Process Management Software (2023-2034) ($MN)       
13 Global Medical Automation Market Outlook, By Imaging & Sensing Automation (2023-2034) ($MN)       
14 Global Medical Automation Market Outlook, By Application (2023-2034) ($MN)       
15 Global Medical Automation Market Outlook, By Hospitals & Clinics (2023-2034) ($MN)       
16 Global Medical Automation Market Outlook, By Diagnostic Laboratories (2023-2034) ($MN)       
17 Global Medical Automation Market Outlook, By Pharmacies & Drug Dispensing (2023-2034) ($MN)       
18 Global Medical Automation Market Outlook, By Home Healthcare (2023-2034) ($MN)       
19 Global Medical Automation Market Outlook, By Research & Academic Institutes (2023-2034) ($MN)       
20 Global Medical Automation Market Outlook, By End User (2023-2034) ($MN)       
21 Global Medical Automation Market Outlook, By Healthcare Providers (2023-2034) ($MN)       
22 Global Medical Automation Market Outlook, By Patients (2023-2034) ($MN)       
23 Global Medical Automation Market Outlook, By Research Organizations (2023-2034) ($MN)       
24 Global Medical Automation Market Outlook, By Pharmaceutical & Biotech Companies (2023-2034) ($MN)       
        
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.        

 

 

List of Figures

RESEARCH METHODOLOGY


Research Methodology

We at Stratistics opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.

Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.

Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.

Data Mining

The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.

Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.

Data Analysis

From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:

  • Product Lifecycle Analysis
  • Competitor analysis
  • Risk analysis
  • Porters Analysis
  • PESTEL Analysis
  • SWOT Analysis

The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.


Data Validation

The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.

We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.

The data validation involves the primary research from the industry experts belonging to:

  • Leading Companies
  • Suppliers & Distributors
  • Manufacturers
  • Consumers
  • Industry/Strategic Consultants

Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.


For more details about research methodology, kindly write to us at info@strategymrc.com

Frequently Asked Questions

In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.

Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.

All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

We have 3 different licensing options available in electronic format.

  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.

All our reports are typically be emailed to you as an attachment.

To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.

We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

Request Customization

We offer complimentary customization of up to 15% with every purchase.

To share your customization requirements, feel free to email us at info@strategymrc.com or call us on +1-301-202-5929. .

Please Note: Customization within the 15% threshold is entirely free of charge. If your request exceeds this limit, we will conduct a feasibility assessment. Following that, a detailed quote and timeline will be provided.

WHY CHOOSE US ?

Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials